RABEPRAZOLE

rabeprazole sodium 10 mg enteric tablet, 28

RABEPRAZOLE (14502G)

rabeprazole sodium 10 mg enteric tablet, 28
14502G
Manner of administration:Oral
General Schedule
Restricted Benefit

Restriction

Indication: Gastro-oesophageal reflux disease

Restriction

Indication: Scleroderma oesophagus
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 56 # of repeats: 5 DPMQ: $20.96 Max safety net: $22.44 General Patient Charge: $25.00
Available brands
APO-Rabeprazole
Parbezol
RABEPRAZOLE-WGR
Rabeprazole Sandoz
Rabeprazole Viatris